141 related articles for article (PubMed ID: 18331322)
21. Three-year registry data on biological treatment for psoriasis: the influence of patient characteristics on treatment outcome.
Driessen RJ; Boezeman JB; van de Kerkhof PC; de Jong EM
Br J Dermatol; 2009 Mar; 160(3):670-5. PubMed ID: 19210502
[TBL] [Abstract][Full Text] [Related]
22. Rapid response of nail psoriasis to etanercept.
Rallis E; Stavropoulou E; Rigopoulos D; Verros C
J Rheumatol; 2008 Mar; 35(3):544-5. PubMed ID: 18322982
[No Abstract] [Full Text] [Related]
23. Etanercept treatment in myasthenia gravis.
Rowin J
Ann N Y Acad Sci; 2008; 1132():300-4. PubMed ID: 18567881
[TBL] [Abstract][Full Text] [Related]
24. Absence of efficacy of oral isotretinoin in hidradenitis suppurativa: a retrospective study based on patients' outcome assessment.
Soria A; Canoui-Poitrine F; Wolkenstein P; Poli F; Gabison G; Pouget F; Viallette C; Revuz J
Dermatology; 2009; 218(2):134-5. PubMed ID: 19060466
[TBL] [Abstract][Full Text] [Related]
25. Leukaemic transformation in patients with haematological disease receiving tumour necrosis factor inhibitors.
Ferrer-Marín F; Amigo ML; Vicente V
Clin Drug Investig; 2012 Jun; 32(6):423-6. PubMed ID: 22550963
[TBL] [Abstract][Full Text] [Related]
26. Successful use of etanercept in type I pityriasis rubra pilaris.
Seckin D; Tula E; Ergun T
Br J Dermatol; 2008 Mar; 158(3):642-4. PubMed ID: 18081896
[No Abstract] [Full Text] [Related]
27. Long-term control with etanercept (Enbrel) of a severe acrodermatitis continua of Hallopeau refractory to infliximab (Remicade).
Thielen AM; Barde C; Marazza G; Saurat JH
Dermatology; 2008; 217(2):137-9. PubMed ID: 18503258
[TBL] [Abstract][Full Text] [Related]
28. Safety and efficacy of once weekly etanercept 0.8 mg/kg in a multicentre 12 week trial in active polyarticular course juvenile idiopathic arthritis.
Horneff G; Ebert A; Fitter S; Minden K; Foeldvari I; Kümmerle-Deschner J; Thon A; Girschick HJ; Weller F; Huppertz HI
Rheumatology (Oxford); 2009 Aug; 48(8):916-9. PubMed ID: 19483091
[TBL] [Abstract][Full Text] [Related]
29. Successful treatment of pemphigus vulgaris with etanercept in four patients.
Shetty A; Marcum CB; Glass LF; Carter JD
J Drugs Dermatol; 2009 Oct; 8(10):940-3. PubMed ID: 19852124
[TBL] [Abstract][Full Text] [Related]
30. [Stable remission of early active rheumatoid arthritis treated with etanercept (Enbrel)].
Kaliterna DM
Reumatizam; 2008; 55(2):60-1. PubMed ID: 19024277
[TBL] [Abstract][Full Text] [Related]
31. Efficacy of adalimumab in recalcitrant hidradenitis suppurativa.
Sotiriou E; Apalla Z; Vakirlis E; Ioannides D
Eur J Dermatol; 2009; 19(2):180-1. PubMed ID: 19153066
[No Abstract] [Full Text] [Related]
32. Treatment of juvenile pityriasis rubra pilaris with etanercept.
Cox V; Lesesky EB; Garcia BD; O'Grady TC
J Am Acad Dermatol; 2008 Nov; 59(5 Suppl):S113-4. PubMed ID: 19119116
[No Abstract] [Full Text] [Related]
33. Safety of combination therapy with rituximab and etanercept for patients with rheumatoid arthritis.
Blank N; Max R; Schiller M; Briem S; Lorenz HM
Rheumatology (Oxford); 2009 Apr; 48(4):440-1. PubMed ID: 19153143
[No Abstract] [Full Text] [Related]
34. Adolescent plaque psoriasis: our experience using etanercept.
Ruiz-Villaverde R; Sánchez-Cano D; Abalos-Medina G
J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):976-7. PubMed ID: 19207668
[No Abstract] [Full Text] [Related]
35. Etanercept for toxic epidermal necrolysis.
Famularo G; Di Dona B; Canzona F; Girardelli CR; Cruciani G
Ann Pharmacother; 2007 Jun; 41(6):1083-4. PubMed ID: 17456541
[No Abstract] [Full Text] [Related]
36. Development of pemphigus vulgaris in a patient with psoriasis treated with etanercept.
Daulat S; Detweiler JG; Pandya AG
J Eur Acad Dermatol Venereol; 2009 Apr; 23(4):483-4. PubMed ID: 18793242
[No Abstract] [Full Text] [Related]
37. Safety and efficacy of up to eight years of continuous etanercept therapy in patients with juvenile rheumatoid arthritis.
Lovell DJ; Reiff A; Ilowite NT; Wallace CA; Chon Y; Lin SL; Baumgartner SW; Giannini EH;
Arthritis Rheum; 2008 May; 58(5):1496-504. PubMed ID: 18438876
[TBL] [Abstract][Full Text] [Related]
38. Acrodermatitis continua resistant to etanercept: therapeutic challenge and unfortunate outcome.
Gokdemir G; Kutlu S; Köşlü A
J Eur Acad Dermatol Venereol; 2009 Mar; 23(3):345-7. PubMed ID: 18554224
[No Abstract] [Full Text] [Related]
39. Life-table analysis of etanercept with or without methotrexate in patients with psoriatic arthritis.
Spadaro A; Ceccarelli F; Scrivo R; Valesini G
Ann Rheum Dis; 2008 Nov; 67(11):1650-1. PubMed ID: 18854519
[No Abstract] [Full Text] [Related]
40. Effective control of psoriasis by etanercept in a patient with HCV-related diseases.
Piccolo D; Di Cesare A; Fargnoli MC; Paoloni M; Vecchiotti S; Peris K
Eur J Dermatol; 2008; 18(4):459-60. PubMed ID: 18573723
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
